Trial intelligence / Profile preview

Dexmedetomidine added to hyperbaric bupivacaine for spinal anesthesia in lower limb surgery

IRCT20241211064021N14Phase 2Recruiting

Sponsor
Hamadan University of Medical Sciences
Start
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial comparing Dexmedetomidine add-on arm with Placebo control arm (2 arms). Primary endpoints: Postoperative pain assessment and Cumulative rescue analgesic use. Started Jan 2026; status: recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on IRCT20241211064021N14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20241211064021N14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call